Vertex Pharmaceuticals's total assets for Q3 2025 were $24.86B, an increase of 3.43% from the previous quarter. VRTX total liabilities were $7.54B for the fiscal quarter, a 9.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.